You are here

Article info

Article menu
PostScript
Letter
Inhibition of YTHDF1 by salvianolic acid overcomes gluten-induced intestinal inflammation

Authors

  • Ane Olazagoitia-Garmendia Department of Biochemistry and Molecular Biology, University of the Basque Country, UPV/EHU, Leioa, Spain Biobizkaia Health Research Institute, Barakaldo, Spain PubMed articlesGoogle scholar articles
  • Henar Rojas-Márquez Biobizkaia Health Research Institute, Barakaldo, Spain Department of Genetics, Physical Anthropology and Animal Physiology, University of the Basque Country, UPV/EHU, Leioa, Spain PubMed articlesGoogle scholar articles
  • Maria del Mar Romero Department of Biochemistry and Physiology, School of Pharmacy and Food Sciences, Universitat de Barcelona, Barcelona, Spain Institut de Biomedicina de la Universitat de Barcelona (IBUB), Universitat de Barcelona, Barcelona, Spain Centro de Investigación Biomédica en Red de Fisiopatología de la Obesidad y la Nutrición (CIBEROBN), Instituto de Salud Carlos III, Madrid, Spain PubMed articlesGoogle scholar articles
  • Pamela Ruiz Research Centre for Experimental Marine Biology and Biotechnology (PiE-UPV/EHU), University of the Basque Country, UPV/EHU, Plentzia, Spain BCTA Research Group, Department of Zoology and Animal Cell Biology, University of the Basque Country, UPV-EHU, Leioa, Spain PubMed articlesGoogle scholar articles
  • Aloña Agirre-Lizaso Department of Liver and Gastrointestinal Diseases, Biodonostia Health Research Institute, Donostia University Hospital, Donostia-san Sebastian, Spain PubMed articlesGoogle scholar articles
  • Yantao Chen State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Science, Beijing, Beijing, China PubMed articlesGoogle scholar articles
  • Maria Jesus Perugorria Department of Liver and Gastrointestinal Diseases, Biodonostia Health Research Institute, Donostia University Hospital, Donostia-san Sebastian, Spain Department of Medicine, Faculty of Medicine and Nursing, University of the Basque Country, UPV/EHU, Leioa, Spain Centro de Investigación Biomédica en Red enfermedades hepaticas y digestivas (CIBERehd), Instituto de Salud Carlos III, Madrid, Spain PubMed articlesGoogle scholar articles
  • Laura Herrero Department of Biochemistry and Physiology, School of Pharmacy and Food Sciences, Universitat de Barcelona, Barcelona, Spain Institut de Biomedicina de la Universitat de Barcelona (IBUB), Universitat de Barcelona, Barcelona, Spain Centro de Investigación Biomédica en Red de Fisiopatología de la Obesidad y la Nutrición (CIBEROBN), Instituto de Salud Carlos III, Madrid, Spain PubMed articlesGoogle scholar articles
  • Dolors Serra Department of Biochemistry and Physiology, School of Pharmacy and Food Sciences, Universitat de Barcelona, Barcelona, Spain Institut de Biomedicina de la Universitat de Barcelona (IBUB), Universitat de Barcelona, Barcelona, Spain Centro de Investigación Biomédica en Red de Fisiopatología de la Obesidad y la Nutrición (CIBEROBN), Instituto de Salud Carlos III, Madrid, Spain PubMed articlesGoogle scholar articles
  • Cheng Luo State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Science, Beijing, Beijing, China Zhongshan Institute for Drug Discovery, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Zhongshan, China PubMed articlesGoogle scholar articles
  • Luis Bujanda Department of Liver and Gastrointestinal Diseases, Biodonostia Health Research Institute, Donostia University Hospital, Donostia-san Sebastian, Spain Department of Medicine, Faculty of Medicine and Nursing, University of the Basque Country, UPV/EHU, Leioa, Spain Centro de Investigación Biomédica en Red enfermedades hepaticas y digestivas (CIBERehd), Instituto de Salud Carlos III, Madrid, Spain PubMed articlesGoogle scholar articles
  • Chuan He Department of Chemistry, Department of Biochemistry and Molecular Biology, University of Chicago, Chicago, Illinois, USA Howard Hughes Medical Institute, Chicago, Illinois, USA PubMed articlesGoogle scholar articles
  • Ainara Castellanos-Rubio Biobizkaia Health Research Institute, Barakaldo, Spain Department of Genetics, Physical Anthropology and Animal Physiology, University of the Basque Country, UPV/EHU, Leioa, Spain Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Instituto de Salud Carlos III, Madrid, Spain IKERBASQUE, Basque Foundation for Science, Bilbao, Spain PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Ainara Castellanos-Rubio, Genetics, Physical Anthropology and Animal Physiology, Universidad del Pais Vasco, Leioa, Basque Country, Spain; ainara.castellanos{at}ehu.eus
View Full Text

Citation

Olazagoitia-Garmendia A, Rojas-Márquez H, Romero MDM, et al
Inhibition of YTHDF1 by salvianolic acid overcomes gluten-induced intestinal inflammation
Gut 2024;73:1590-1592.

Publication history

  • Received June 9, 2023
  • Accepted October 11, 2023
  • First published October 31, 2023.
Online issue publication 
August 08, 2024

Article Versions

  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.